Design, Synthesis and Cancer Cell Line Activities of Pyrazolo[3,4-b]pyridine Derivatives
Open Access
- 1 January 2012
- journal article
- Published by Scientific Research Publishing, Inc. in Open Journal of Medicinal Chemistry
- Vol. 02 (03), 78-88
- https://doi.org/10.4236/ojmc.2012.23010
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001–7PharmacoEconomics, 2012
- Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine: Evaluation of a Novel Selective Inhibitor of Cyclin-Dependent Kinases with Antiproliferative ActivityJournal of Medicinal Chemistry, 2011
- Targeting cancer with small molecule kinase inhibitorsNature Reviews Cancer, 2009
- Phenylacetone as Building Blocks in Heterocyclic Synthesis: Synthesis of Polyfunctionally-Substituted Pyridines, and fused PyridinesPhosphorus, Sulfur, and Silicon and the Related Elements, 2007
- How many drug targets are there?Nature Reviews Drug Discovery, 2006
- Playing dirtyNature, 2005
- Pyrazolo[3,4-c]pyridazines as Novel and Selective Inhibitors of Cyclin-Dependent KinasesJournal of Medicinal Chemistry, 2005
- Roscovitine and Other Purines as Kinase Inhibitors. From Starfish Oocytes to Clinical TrialsAccounts of Chemical Research, 2003
- Glivec (STI571, imatinib), a rationally developed, targeted anticancer drugNature Reviews Drug Discovery, 2002
- Inhibition of Cyclin‐Dependent Kinases by Purine AnaloguesJBIC Journal of Biological Inorganic Chemistry, 1994